Shu Zhang
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 24, 2025
Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer.Yixuan Zhang, Ranran Yu, Qi Li
|Nov 15, 2023
CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma.Yin Zhang, Ranran Yu, Cheng Zhao
|Aug 23, 2023
Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis.Shu Zhang, Wen Fang, Siqi Zhou
|Feb 28, 2023
Sedation Is Associated with Higher Polyp and Adenoma Detection Rates during Colonoscopy: A Retrospective Cohort Study.Chenghu Xu, Dehua Tang, Ying Xie
|Oct 19, 2022
Pirfenidone-loaded exosomes derived from pancreatic ductal adenocarcinoma cells alleviate fibrosis of premetastatic niches to inhibit liver metastasis.Jing Zhao, Yun Zhu, Zhuojin Li
|May 13, 2022
Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations.Yixuan Zhang, Jianzhuang Wu, Yao Fu
Pageof 1
